• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含 N-取代胍的奥司他韦类似物作为强效神经氨酸酶抑制剂。

Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.

机构信息

Department of Medicinal Chemistry and Chemical Biology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University , Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.

出版信息

J Med Chem. 2014 Apr 10;57(7):3154-60. doi: 10.1021/jm401977j. Epub 2014 Mar 31.

DOI:10.1021/jm401977j
PMID:24649802
Abstract

A series of oseltamivir analogues bearing an N-substituted guanidine unit were prepared and evaluated as inhibitors of neuraminidases from four strains of influenza. The two most potent analogues identified contain relatively small N-guanidine substituents (N-methyl and N-hydroxyl) and display enhanced inhibition with IC50 values in the low nanomolar range against neuraminidases from wild-type and oseltamivir-resistant strains. Potential advantages of including the N-hydroxyguanidine moiety in neuraminidase inhibitors are also discussed.

摘要

制备了一系列含有 N-取代胍基单元的奥司他韦类似物,并将其作为来自四种流感株的神经氨酸酶抑制剂进行了评估。鉴定出的两种最有效的类似物含有相对较小的 N-胍基取代基(N-甲基和 N-羟基),并且对野生型和奥司他韦耐药株的神经氨酸酶显示出增强的抑制作用,IC50 值在纳摩尔范围内。还讨论了在神经氨酸酶抑制剂中包含 N-羟基胍基部分的潜在优势。

相似文献

1
Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.含 N-取代胍的奥司他韦类似物作为强效神经氨酸酶抑制剂。
J Med Chem. 2014 Apr 10;57(7):3154-60. doi: 10.1021/jm401977j. Epub 2014 Mar 31.
2
The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.阻力最小的途径:降低流感对奥司他韦敏感性的机制
J Mol Biol. 2016 Feb 13;428(3):533-537. doi: 10.1016/j.jmb.2015.12.019. Epub 2015 Dec 31.
3
[Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].[帕拉米韦。一种用于治疗流感的新型强效神经氨酸酶抑制剂]
Rev Esp Quimioter. 2006 Dec;19(4):317-22.
4
[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].神经氨酸酶抑制剂在甲型流感病毒感染治疗中的作用
Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19.
5
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.基于晶体神经氨酸酶结构修饰奥司他韦的类似物抑制剂用于治疗耐药H5N1病毒。
Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. doi: 10.1016/j.bbrc.2007.08.025. Epub 2007 Aug 13.
6
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.基于结构的 N-取代奥司他韦衍生物的优化作为强效抗流感 A 病毒药物,对奥司他韦耐药 N1-H274Y 变异株的活性显著提高。
J Med Chem. 2018 Nov 21;61(22):9976-9999. doi: 10.1021/acs.jmedchem.8b01065. Epub 2018 Nov 6.
7
Synthesis and biological evaluation of NH-acyl oseltamivir analogues as potent neuraminidase inhibitors.作为强效神经氨酸酶抑制剂的NH-酰基奥司他韦类似物的合成及生物学评价
Eur J Med Chem. 2017 Dec 1;141:648-656. doi: 10.1016/j.ejmech.2017.10.004. Epub 2017 Oct 5.
8
Influenza virus susceptibility and resistance to oseltamivir.流感病毒对奥司他韦的敏感性和耐药性。
Antivir Ther. 2007;12(4 Pt B):603-16.
9
Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase.发现含酰腙的奥司他韦类似物作为有效的流感 A 神经氨酸酶抑制剂。
Eur J Med Chem. 2021 Oct 5;221:113567. doi: 10.1016/j.ejmech.2021.113567. Epub 2021 May 23.
10
Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.酰基胍型奥司他韦羧酸盐衍生物作为强效神经氨酸酶抑制剂的发现。
Bioorg Med Chem. 2017 May 15;25(10):2772-2781. doi: 10.1016/j.bmc.2017.03.052. Epub 2017 Mar 27.

引用本文的文献

1
DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors.DNA 连接抑制剂抗体检测法(DIANA)作为一种新的筛选流感神经氨酸酶抑制剂的方法。
Biochem J. 2018 Dec 10;475(23):3847-3860. doi: 10.1042/BCJ20180764.
2
Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.设计和合成约束双环分子作为流感 A 神经氨酸酶抑制剂的候选物。
PLoS One. 2018 Feb 28;13(2):e0193623. doi: 10.1371/journal.pone.0193623. eCollection 2018.
3
Fluorination of some highly functionalized cycloalkanes: chemoselectivity and substrate dependence.
一些高度官能化环烷烃的氟化反应:化学选择性与底物依赖性
Beilstein J Org Chem. 2017 Nov 6;13:2364-2371. doi: 10.3762/bjoc.13.233. eCollection 2017.
4
Progress of small molecular inhibitors in the development of anti-influenza virus agents.抗流感病毒药物研发中小分子抑制剂的进展
Theranostics. 2017 Feb 8;7(4):826-845. doi: 10.7150/thno.17071. eCollection 2017.
5
Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity.流感神经氨酸酶抑制剂:合成方法、衍生物及生物活性
Molecules. 2016 Nov 11;21(11):1513. doi: 10.3390/molecules21111513.
6
New small-molecule drug design strategies for fighting resistant influenza A.对抗耐药甲型流感的新型小分子药物设计策略
Acta Pharm Sin B. 2015 Sep;5(5):419-30. doi: 10.1016/j.apsb.2015.07.006. Epub 2015 Sep 6.